Jim Sullivan
Chief Executive Officer at Vanqua Bio
Greater Chicago Area
Overview
Work Experience
Chief Executive Officer
2019 - Current
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.
Raised $129,979,987.00 from Logos Capital, OUP (Osage University Partners), OrbiMed, Omega Funds, Casdin Capital, Avoro Ventures, Eli Lilly, Pontifax and Surveyor Capital.
Venture Partner
2019
OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals for medical devices and diagnostics.
Adjunct Professor, Department of Pharmacology
2009
Vice President Global Discovery
2013 - 2018
AbbVie is a pharmaceutical company that discovers, develops, and markets medicines.
Raised $15,000,249,999.00.
Vice President Global Pharmaceutical Discovery
2008 - 2012
Vice President, Neuroscience Discovery
2001 - 2008
Director Neuroscience Discovery
1997 - 2000
Project Leader
1995 - 1997
The Clara Abbott Foundation is a non-profit firm aimed to assist families, in gaining financial security for the rest of their lives.
Sr Research Scientist, Neuroscience Discovery
1991 - 1993
The Clara Abbott Foundation is a non-profit firm aimed to assist families, in gaining financial security for the rest of their lives.
Research Scientist
1990 - 1991
Postdoctoral Fellow, Department of Neurobiology
1987 - 1990